Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibryga in pediatric congenital fibrinogen deficiency
NCT02408484Phase 3Completed
- Sponsor
- Octapharma
- Start
- Dec 2015
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by Octapharma. Started Dec 2015; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT02408484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408484.